Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19.
作者信息
Maquet Julien, Lafaurie Margaux, Sommet Agnès, Moulis Guillaume
机构信息
Service de Médecine Interne, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Centre d'investigation clinique 1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
出版信息
Br J Haematol. 2020 Sep;190(5):e276-e279. doi: 10.1111/bjh.16950. Epub 2020 Aug 31.
Abstract
摘要
相似文献
1
Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19.血小板减少症与因新冠肺炎住院患者的不良预后独立相关。
Br J Haematol. 2020 Sep;190(5):e276-e279. doi: 10.1111/bjh.16950. Epub 2020 Aug 31.
2
Platelets in Coronavirus Disease 2019.2019冠状病毒病中的血小板
Semin Thromb Hemost. 2020 Oct;46(7):823-825. doi: 10.1055/s-0040-1710006. Epub 2020 Apr 30.
3
Mechanism of thrombocytopenia in COVID-19 patients.新型冠状病毒肺炎患者血小板减少的机制。
Ann Hematol. 2020 Jun;99(6):1205-1208. doi: 10.1007/s00277-020-04019-0. Epub 2020 Apr 15.
4
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.血液系统恶性肿瘤的COVID-19患者中SARS-CoV-2 RNA的不良预后和长期持续存在；国王学院医院的经验。
Br J Haematol. 2020 Sep;190(5):e279-e282. doi: 10.1111/bjh.16935. Epub 2020 Aug 10.
5
Sleep Apnea and COVID-19 Mortality and Hospitalization.睡眠呼吸暂停与新冠病毒疾病的死亡率及住院率
Am J Respir Crit Care Med. 2020 Nov 15;202(10):1462-1464. doi: 10.1164/rccm.202006-2252LE.
6
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
7
Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review.血小板减少作为新型冠状病毒肺炎的初始表现；病例系列及文献综述
Br J Haematol. 2020 Jun;189(6):1057-1058. doi: 10.1111/bjh.16769. Epub 2020 Jun 2.
8
Thrombocytopenia and its association with mortality in patients with COVID-19.血小板减少症及其与 COVID-19 患者死亡率的关系。
J Thromb Haemost. 2020 Jun;18(6):1469-1472. doi: 10.1111/jth.14848. Epub 2020 May 4.
9
Secondary HLH is uncommon in severe COVID-19.继发性噬血细胞性淋巴组织细胞增生症（HLH）在重症新型冠状病毒肺炎（COVID-19）中并不常见。
Br J Haematol. 2020 Sep;190(5):e283-e285. doi: 10.1111/bjh.16934. Epub 2020 Aug 10.
10
Mechanisms involved in the development of thrombocytopenia in patients with COVID-19.与 COVID-19 患者血小板减少症发展相关的机制。
Thromb Res. 2020 Sep;193:110-115. doi: 10.1016/j.thromres.2020.06.008. Epub 2020 Jun 5.
引用本文的文献
1
Non-linear relationship between platelet count and 30-day in-hospital mortality in ICU patients with acute myocardial infarction: a multicenter retrospective cohort study.急性心肌梗死ICU患者血小板计数与30天院内死亡率的非线性关系：一项多中心回顾性队列研究
Sci Rep. 2025 Jul 1;15(1):21821. doi: 10.1038/s41598-025-06317-x.
2
Combination of Evans syndrome and COVID-19: a systematic review of reported cases.伊文氏综合征与新型冠状病毒肺炎的合并症：已报告病例的系统评价
Blood Transfus. 2025 Jul-Aug;23(4):365-378. doi: 10.2450/BloodTransfus.860. Epub 2025 Feb 6.
3
Outcomes and Risk Factors in Patients with Hematologic Malignancies Following Late-Stage SARS-CoV-2 Infection.晚期严重急性呼吸综合征冠状病毒2感染后血液系统恶性肿瘤患者的结局及危险因素
J Multidiscip Healthc. 2024 Dec 8;17:5853-5865. doi: 10.2147/JMDH.S491098. eCollection 2024.
4
Platelet Aggregation Alterations in Patients with Severe Viral Infection Treated at the Intensive Care Unit: Implications for Mortality Risk.重症监护病房治疗的严重病毒感染患者血小板聚集的改变：对死亡风险的影响
Pathogens. 2024 Sep 10;13(9):778. doi: 10.3390/pathogens13090778.
5
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.新型冠状病毒肺炎血栓形成：区分病理、机制、表型特征及管理
J Thromb Thrombolysis. 2025 Jan;58(1):15-49. doi: 10.1007/s11239-024-03028-4. Epub 2024 Aug 23.
6
Changes in respiratory infection trends during the COVID-19 pandemic in patients with haematologic malignancy.COVID-19 大流行期间血液恶性肿瘤患者呼吸道感染趋势的变化。
BMC Pulm Med. 2024 May 26;24(1):259. doi: 10.1186/s12890-024-03071-0.
7
Special Issue "COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies".特刊征稿：“COVID-19 凝血障碍：病理生理学和治疗方法的进展”。
Int J Mol Sci. 2024 Mar 21;25(6):3548. doi: 10.3390/ijms25063548.
8
Evaluation of hematological changes and immune response biomarkers as a prognostic factor in critical patients with COVID-19.评估 COVID-19 危重症患者的血液学变化和免疫反应生物标志物作为预后因素。
PLoS One. 2024 Feb 29;19(2):e0297490. doi: 10.1371/journal.pone.0297490. eCollection 2024.
9
SARS-CoV-2 Omicron variant infection affects blood platelets, a comparative analysis with Delta variant.严重急性呼吸综合征冠状病毒2型奥密克戎变异株感染对血小板的影响：与德尔塔变异株的比较分析
Front Immunol. 2023 Sep 27;14:1231576. doi: 10.3389/fimmu.2023.1231576. eCollection 2023.
10
Characteristics, outcomes, and risk factors for in-hospital mortality of COVID-19 patients: A retrospective study in Thailand.新型冠状病毒肺炎患者院内死亡的特征、结局及危险因素：泰国的一项回顾性研究
Front Med (Lausanne). 2023 Jan 4;9:1061955. doi: 10.3389/fmed.2022.1061955. eCollection 2022.
本文引用的文献
1
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.COVID-19 和凝血：SARS-CoV-2 感染的出血和血栓形成表现。
Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.
2
The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants.重症新型冠状病毒肺炎与血小板计数低之间的关联：来自31项涉及7613名参与者的观察性研究的证据。
Br J Haematol. 2020 Jul;190(1):e29-e33. doi: 10.1111/bjh.16817. Epub 2020 Jun 9.
3
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic.COVID-19 大流行期间成人免疫性血小板减少症管理的实用指南。
Br J Haematol. 2020 Jun;189(6):1038-1043. doi: 10.1111/bjh.16775. Epub 2020 Jun 2.
4
What do monitoring platelet counts in COVID-19 teach us?监测新型冠状病毒肺炎患者的血小板计数能给我们带来什么启示？
J Thromb Haemost. 2020 Aug;18(8):2071-2072. doi: 10.1111/jth.14879. Epub 2020 May 12.
5
Thrombocytopenia and its association with mortality in patients with COVID-19.血小板减少症及其与 COVID-19 患者死亡率的关系。
J Thromb Haemost. 2020 Jun;18(6):1469-1472. doi: 10.1111/jth.14848. Epub 2020 May 4.
6
Hematological findings and complications of COVID-19.COVID-19 的血液学表现及并发症。
Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Platelet counts of adults upon acute hospital admission to internal medicine units are a predictor of mortality.成年人在因内科急症入院时的血小板计数是预测死亡率的一个指标。
Ann Hematol. 2020 Mar;99(3):451-457. doi: 10.1007/s00277-019-03855-z. Epub 2020 Jan 13.
9
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia.住院时血小板减少症和血小板增多症可预测社区获得性肺炎患者的死亡率。
Chest. 2010 Feb;137(2):416-20. doi: 10.1378/chest.09-0998. Epub 2009 Oct 16.
10
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia.社区获得性肺炎住院患者临床治疗失败的发生率、病因、时间及危险因素。
Chest. 2008 Nov;134(5):955-962. doi: 10.1378/chest.08-0334. Epub 2008 Jun 26.
Zotero 插件